Hillsdale Investment Management Inc. Amgen Inc Transaction History

Hillsdale Investment Management Inc.

$1.13 Billion
Q1 2024

A detailed history of Hillsdale Investment Management Inc. transactions in Amgen Inc stock. As of the latest transaction made, Hillsdale Investment Management Inc. holds 1,400 shares of AMGN stock, worth $435,078. This represents 0.04% of its overall portfolio holdings.

Number of Shares

1,400

Previous 970 44.33%

Holding current value

$435,078

Previous $279,000 42.65%

% of portfolio

0.04%

Previous 0.02%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$268.87 - $324.56 $115,614 - $139,560	430 Added 44.33%	1,400 $398,000
Q4 2023 Feb 09, 2024	BUY	$255.7 - $288.46 $81,824 - $92,307	320 Added 49.23%	970 $279,000
Q3 2023 Nov 09, 2023	BUY	$218.65 - $271.46 $55,974 - $69,493	256 Added 64.97%	650 $174,000
Q1 2023 May 10, 2023	SELL	$225.79 - $275.2 $348,845 - $425,184	-1,545 Reduced 79.68%	394 $95,000
Q4 2022 Feb 13, 2023	SELL	$229.03 - $291.01 $154,595 - $196,431	-675 Reduced 25.82%	1,939 $509,000

Q3 2022 Nov 10, 2022	BUY	$224.46 - $253.15 $495,158 - $558,448	2,206 Added 540.69%	2,614 $590,000
Q2 2022 Aug 12, 2022	BUY	$230.71 - $256.74 $19,148 - $21,309	83 Added 25.54%	408 $99,000
Q1 2022 Apr 28, 2022	BUY	$219.27 - $242.57 $19,734 - $21,831	90 Added 38.3%	325 $79,000
Q1 2021 Apr 22, 2021	SELL	$221.91 - $258.6 $49,929 - $58,185	-225 Reduced 48.91%	235 $58,000
Q4 2020 Feb 09, 2021	SELL	$216.38 - $257.67 $380,828 - $453,499	-1,760 Reduced 79.28%	460 $106,000
Q3 2020 Nov 13, 2020	SELL	$234.65 - $260.95 $157,215 - $174,836	-670 Reduced 23.18%	2,220 $564,000
Q2 2020 Aug 11, 2020	SELL	$197.81 - $242.74 $73,189 - $89,813	-370 Reduced 11.35%	2,890 $681,000
Q1 2020 May 12, 2020	SELL	$182.24 - $241.7 $1,822 - $2,417	-10 Reduced 0.31%	3,260 $661,000
Q3 2019 Nov 13, 2019	SELL	$174.11 - $208.62 $6,964 - $8,344	-40 Reduced 1.21%	3,270 $633,000
Q2 2019 Aug 02, 2019	BUY	$166.7 - $195.41 $46,676 - $54,714	280 Added 9.24%	3,310 $609,000
Q1 2019 May 13, 2019	BUY	$180.87 - $203.88 $126,609 - $142,716	700 Added 30.04%	3,030 $575,000
Q2 2018 Aug 13, 2018	SELL	$166.05 - $186.51 $1,660 - $1,865	-10 Reduced 0.43%	2,330 $430,000
Q4 2017 Feb 13, 2018	BUY	$168.79 - $188.59 $67,516 - $75,436	400 Added 20.62%	2,340 $407,000
Q2 2017 Aug 14, 2017	BUY	N/A	1,940	1,940 $334,000

Others Institutions Holding AMGN

# of Institutions

2,932

Shares Held

401M

Call Options Held

6.59M

Put Options Held

6.6M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $166B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hillsdale Investment Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Hillsdale Investment Management Inc. with notifications on news.

Account

Hillsdale Investment Management Inc. Amgen Inc Transaction History